Transcription of (incidence - KineretRx.com
{{id}} {{{paragraph}}}
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KINERET safely and effectively. See full prescribing information for KINERET. KINERET (anakinra) injection, for subcutaneous use Initial Approval: 2001 ----------------------------RECENT MAJOR CHANGES-------------------------- Warnings and Precautions ( ) ----------------------------INDICATIONS AND USAGE--------------------------- Kineret is an interleukin-1 receptor antagonist indicated for.
5.6 Neutrophil Count Patients receiving Kineret may experience a decrease in neutrophil counts. Neutrophil counts should therefore be assessed prior to …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}